Table 2.
Patients’ clinical presentation and outcomes of the COVID-19 patients.
| Variable | Frequency | % |
|---|---|---|
| Initial presentation (N = 2170) | ||
| Mild | 1251 | 57.7 |
| Moderate | 770 | 35.5 |
| Severe | 107 | 4.9 |
| Critical | 42 | 1.9 |
| The presence of symptoms at presentation (N = 2170) | ||
| Symptomatic | 906 | 41.7 |
| Asymptomatic | 1264 | 58.3 |
| Co-morbidity (N = 2184) | ||
| Yes | 492 | 22.5 |
| No | 1692 | 77.5 |
| Number of co-morbidities (n = 492) | ||
| 1 | 367 | 74.6 |
| 2 | 114 | 23.2 |
| 3 or more | 11 | 2.2 |
| Type of co-morbidities | ||
| Hypertension | 365 | 16.7 |
| Diabetes | 149 | 6.8 |
| Asthma | 50 | 2.3 |
| Cancer | 9 | 0.4 |
| Kidney disease | 14 | 0.6 |
| Sickle cell disease | 7 | 0.3 |
| HIV | 7 | 0.3 |
| Length of hospital stay (days) | ||
| Less than 5 | 229 | 12.3 |
| 6-10 | 475 | 25.4 |
| 11-15 | 912 | 48.8 |
| 16-20 | 165 | 8.83 |
| >20 | 88 | 4.71 |
| Outcome (n = 1798) | ||
| Discharged | ||
| Died | 1725 | 95.9 |
| 73 | 4.1 |